UBQU (Ubiquitech Software) Total Receivables: $0.00 Mil (As of Aug. 2023)


What is Ubiquitech Software Total Receivables?

Ubiquitech Software UBQU -95.00% Total Receivables is $0.00 Mil as of Aug. 2023.

Ubiquitech Software's Total Receivables for the quarter that ended in Aug. 2023 was $0.00 Mil.

Ubiquitech Software Total Receivables Related Terms

Ubiquitech Software Total Receivables Historical Data

* Premium members only.

The historical data trend for Ubiquitech Software's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ubiquitech Software Total Receivables Chart

Ubiquitech Software Annual Data
Trend Aug08
Total Receivables
0.00

Ubiquitech Software Quarterly Data
Nov07 Feb08 May08 Aug08 Nov08 Feb09 May09 Aug09 Nov09 Feb10 May10 Aug22 Aug23
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ubiquitech Software Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.00 Mil mean?
Ubiquitech Software (UBQU) has a Total Receivables of $0.00 Mil as of Aug. 2023. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Ubiquitech Software and its competitors.
Is Ubiquitech Software's Total Receivables too high?
Ubiquitech Software's current Total Receivables is $0.00 Mil.
How does Ubiquitech Software's Total Receivables compare to ZTS?
Ubiquitech Software's Total Receivables of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Ubiquitech Software and its competitors. Ubiquitech Software's current Total Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ubiquitech Software stock overvalued right now?
Ubiquitech Software (UBQU) has a current Total Receivables of $0.00 Mil. The current Total Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Ubiquitech Software (UBQU), the current Total Receivables is $0.00 Mil as of Aug. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ubiquitech Software Business Description

Address 3570 East 12th Avenue, Denver, CO, USA, 80206
Ubiquitech Software Corp is a United States-based multi-media, multi-faceted company. It is engaged in utilizing world-wide internet marketing, direct response television, radio, and traditional marketing to drive traffic to the new industries. The company also focuses on developing Cannabidiol (CBD) Hemp derived products. It owns the proprietary CBD brand CannazALL. The company offers the products through its internally designed and operated web portal.